Autonomic neuropathy in experimental models of diabetes mellitus

Keyphrases

• Type 1 Diabetes Mellitus (T1DM) 100%
• Diabetic Autonomic Neuropathy 100%
• Neuropathology 100%
• Sympathetic Ganglia 100%
• Autonomic Neuropathy 100%
• Diabetic 66%
• End Organ 66%
• Parasympathetic Ganglia 66%
• Intramural Ganglia 66%
• Nerve Terminal 33%
• Pathophysiology 33%
• Specific Inhibitor 33%
• Diabetes 33%
• Human Disease 33%
• Ischemia 33%
• Human Subjects 33%
• Neurotrophic 33%
• Experimental Animals 33%
• Rodent Models 33%
• Patient Mortality 33%
• Bowel 33%
• Pathogenic Mechanism 33%
• Sympathetic Nervous System 33%
• Patient Morbidity 33%
• Effector Pathways 33%
• Antioxidant 33%
• Animal Subjects 33%
• Sensory Neuropathy 33%
• Axonal Pathology 33%
• Pathway-specific 33%
• Enteric Nervous System 33%
• Sensory Nervous System 33%
• Complex Pathways 33%
• Autonomic Dysfunction 33%
• Polyol Pathway 33%
• Autonomic Element 33%
• Sympathetic Innervation 33%
• Parasympathetic Nervous System 33%
• Untoward Effect 33%
• Visceral Sensory 33%
• Dendritic Pathology 33%
• Interstitial Cells of Cajal 33%
• Global Explanations 33%
• Advanced Glycosylation End Products 33%

Neuroscience

• Diabetes Mellitus 100%
• Autonomic Neuropathy 100%
• Sympathetic Ganglion 50%
• Parasympathetic Ganglion 33%
• Afferent Nerve Fiber 16%
• Ganglion 16%
• Somatics 16%
• Enteric Nervous System 16%
• Antioxidant 16%
• Sympathetic Nervous System 16%
• Parasympathetic Nervous System 16%
• Sympathetic Innervation 16%
• Dysautonomia 16%
• Advanced Glycation End Product 16%
• Polyol 16%
• Interstitial Cell of Cajal 16%
• Ischemia 16%
• Neuropathy 16%